Oasmia

Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

Read more

Press releases

September 15, 2019 Regulatory press release
The Nomination Committee’s proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
September 5, 2019 Regulatory press release
Oasmia publishes its annual report and adjusts accounts due to write-downs
September 4, 2019
Oasmia completes its management team

All press releases

Financial reports

Calendar

September 26, 2019 Interim Report May – July 2019
September 26, 2019 Annual General Meeting
December 20, 2019 Interim Report May – October 2019

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK